{"id":17058,"date":"2013-09-16T02:30:00","date_gmt":"2013-09-16T00:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/indagine-50-americani-si-fida-dei-siti-delle-aziende\/"},"modified":"2013-09-16T02:30:00","modified_gmt":"2013-09-16T00:30:00","slug":"indagine-50-americani-si-fida-dei-siti-delle-aziende","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/indagine-50-americani-si-fida-dei-siti-delle-aziende\/","title":{"rendered":"Survey, 50% Americans trust company sites"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; line-height: 14.25pt; margin: 0cm 0cm 0pt; background: white\"><span style=\"font-family: &quot;Georgia&quot;,&quot;serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: IT\"><font size=\"3\">BERN \u2013 Pharmaceutical sales in Switzerland increased by 2.2% last year, against 0.9% in 2011. Taking into account demographic growth, the increase in the elderly population and the expansion of the offer of medicines, this progression is to be considered moderate. This is what emerges from a study conducted by the IMS Health Institute and presented today in Bern to the press by Interpharma, the Association of Swiss Pharmaceutical Research Companies, and by vips, the Association of Pharmaceutical Companies in Switzerland.<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 14.25pt; margin: 0cm 0cm 10pt; background: white; mso-margin-bottom-alt: auto\"><span style=\"font-family: &quot;Georgia&quot;,&quot;serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: IT\"><font size=\"3\">Excluding price corrections \u2013 especially downwards \u2013 that occurred during the year, revenue growth would have been 5%, indicated Gregor Pfister of IMS Health. Conversely, the new drugs launched in 2012 had a positive influence on sales.<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 14.25pt; margin: 0cm 0cm 10pt; background: white; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto\"><span style=\"font-family: &quot;Georgia&quot;,&quot;serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: IT\"><font size=\"3\">According to the analysis conducted by IMS Health on the basis of the prices indicated by the manufacturers, in 2012 the turnover reached 5.08 billion francs, up by 2.2% compared to the previous year (4.97 billion) .<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 14.25pt; margin: 0cm 0cm 10pt; background: white; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto\"><span style=\"font-family: &quot;Georgia&quot;,&quot;serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: IT\"><font size=\"3\">Three segments, which together account for about a quarter of the entire market, drove sales: drugs against autoimmune diseases, anticancer drugs and antivirals. In fact, immunosuppressants have recorded a progression of 16% to around 450 million francs. The turnover of anticancer drugs grew by 9.9%, while that of antivirals by 10.3%.<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 14.25pt; margin: 0cm 0cm 10pt; background: white; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto\"><span style=\"font-family: &quot;Georgia&quot;,&quot;serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: IT\"><font size=\"3\">As regards sales of drugs reimbursed by health insurance funds, growth was above average, with 3.6%, at 4.15 billion francs. Many in-patent medicines have lost ground to off-patent medicines and generics. The latter recorded above-average growth: +11.7%, to 548 million francs.<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 14.25pt; margin: 0cm 0cm 10pt; background: white; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto\"><span style=\"font-family: &quot;Georgia&quot;,&quot;serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: IT\"><font size=\"3\">According to the IMS Health survey, no<\/p>","protected":false},"excerpt":{"rendered":"<p>BERNA &#8211; Le vendite di farmaci in Svizzera sono progredite lo scorso anno del 2,2%, contro lo 0,9% del 2011. Tenuto conto della crescita demografica, dell&#8217;aumento della popolazione anziana e dell&#8217;ampliamento dell&#8217;offerta di medicamenti, questa progressione &egrave; da considerare moderata. &Egrave; quanto emerge da uno studio condotto dall&#8217;Istituto IMS Health e presentato oggi a Berna &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17058","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17058"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17058\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}